$31.49▴ 0.03%
End-of-day close · 2026-07-14
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$0.94cash per $1 profit
Healthy
Most of its reported profit shows up as real cash.
Valuation
85th pctvs its own history
Rich
Its valuation sits in the richer end of its own recent range.
Revenue growth
+5.6%year over year
Decelerating
Growth is positive but slowing.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
Fair value
Undervalued
Trading about 23% below our fair-value range
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
Catalyst Pharmaceuticals, Inc. turns 94¢ of every reported profit-dollar into real cash. Most of its reported profit shows up as real cash. Growth is positive but slowing. Its valuation sits in the richer end of its own recent range.
Key numbers
Valuation
EPS (TTM)$1.74
TTM (trailing 12 months, through fiscal Q1 FY2026)
Profitability
Net margin37.1%
TTM (trailing 12 months, through fiscal Q1 FY2026)
Size
Revenue (TTM)$596.96M
TTM (trailing 12 months, through fiscal Q1 FY2026)
Recent news
Sentiment · last 30 days1 article
1 bullish0 neutral0 bearish
Signals and key numbers are from the fiscal Q1 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.